DIN 02284650 — AZILECT 1 MG
AZILECT is a tablet of Rasagiline marketed by TEVA CANADA LIMITED. The full Rasagiline monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02284650
- Brand name
- AZILECT
- Active ingredient
- Rasagiline
- Strength
- 1 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Monoamine oxidase type B (MAO-B) inhibitor (antiparkinson agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Rasagiline products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02404680 | APO-RASAGILINE | 0.5 MG | TABLET | APOTEX INC | MARKETED |
| 02404699 | APO-RASAGILINE | 1 MG | TABLET | APOTEX INC | MARKETED |
| 02284642 | AZILECT | 0.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02491974 | JAMP RASAGILINE | 0.5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02491982 | JAMP RASAGILINE | 1 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02418436 | TEVA-RASAGILINE | 0.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02418444 | TEVA-RASAGILINE | 1 MG | TABLET | TEVA CANADA LIMITED | MARKETED |